JPWO2022054924A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022054924A5
JPWO2022054924A5 JP2022548363A JP2022548363A JPWO2022054924A5 JP WO2022054924 A5 JPWO2022054924 A5 JP WO2022054924A5 JP 2022548363 A JP2022548363 A JP 2022548363A JP 2022548363 A JP2022548363 A JP 2022548363A JP WO2022054924 A5 JPWO2022054924 A5 JP WO2022054924A5
Authority
JP
Japan
Prior art keywords
transplantation
neural
transplant
cells
sheet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548363A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022054924A1 (https=
JP7760131B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/033386 external-priority patent/WO2022054924A1/ja
Publication of JPWO2022054924A1 publication Critical patent/JPWO2022054924A1/ja
Publication of JPWO2022054924A5 publication Critical patent/JPWO2022054924A5/ja
Application granted granted Critical
Publication of JP7760131B2 publication Critical patent/JP7760131B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548363A 2020-09-11 2021-09-10 移植用組織のための媒体 Active JP7760131B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020153248 2020-09-11
JP2020153248 2020-09-11
PCT/JP2021/033386 WO2022054924A1 (ja) 2020-09-11 2021-09-10 移植用組織のための媒体

Publications (3)

Publication Number Publication Date
JPWO2022054924A1 JPWO2022054924A1 (https=) 2022-03-17
JPWO2022054924A5 true JPWO2022054924A5 (https=) 2024-09-06
JP7760131B2 JP7760131B2 (ja) 2025-10-27

Family

ID=80631731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548363A Active JP7760131B2 (ja) 2020-09-11 2021-09-10 移植用組織のための媒体

Country Status (6)

Country Link
US (1) US20230310614A1 (https=)
EP (1) EP4201428A4 (https=)
JP (1) JP7760131B2 (https=)
CN (1) CN116194079A (https=)
CA (1) CA3194364A1 (https=)
WO (1) WO2022054924A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3254454A1 (en) * 2022-03-16 2025-03-04 Racthera Co., Ltd. METHOD OF TRANSPLANTATION

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
AU717743B2 (en) 1995-12-13 2000-03-30 Regents Of The University Of California, The Nuclear receptor ligands and ligand binding domains
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
US6344481B1 (en) 1999-03-01 2002-02-05 Pfizer Inc. Thyromimetic antiobesity agents
US6280718B1 (en) 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells
ATE310733T1 (de) 2000-04-21 2005-12-15 Pfizer Prod Inc Thyroid-rezeptorliganden
GB0015205D0 (en) 2000-06-21 2000-08-09 Karobio Ab Bioisosteric thyroid receptor ligands and method
WO2002051805A1 (de) 2000-12-27 2002-07-04 Bayer Aktiengesellschaft Indol-derivate
JP4225791B2 (ja) 2001-05-18 2009-02-18 キッセイ薬品工業株式会社 肝癌の予防または再発抑制剤
DK1262177T3 (da) 2001-05-31 2006-11-20 Pfizer Prod Inc Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner
WO2002101057A1 (fr) 2001-06-08 2002-12-19 Dnavec Research Inc. Transfert genique dans des cellules souches embryonnaires de primate a l'aide d'un virus de l'immunodeficience simienne de pseudo type vsv-g utilise comme vecteur
EP1499578A2 (en) 2001-08-24 2005-01-26 Karo Bio Ab Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
US7230031B2 (en) 2002-01-30 2007-06-12 Kissei Pharmaceutical Co., Ltd. Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
WO2003068053A2 (en) 2002-02-14 2003-08-21 Photogenesis, Inc. Subretinal implantation device and surgical cannulas for use therewith
GB0208384D0 (en) 2002-04-11 2002-05-22 Karobio Ab Novel compounds
WO2003094845A2 (en) 2002-05-08 2003-11-20 Bristol-Myers Squibb Company Pyridine-based thyroid receptor ligands
WO2004066929A2 (en) 2003-01-24 2004-08-12 Bristol-Myers Squibb Company Cycloalkyl containing anilide ligands for the thyroid receptor
US7557143B2 (en) 2003-04-18 2009-07-07 Bristol-Myers Squibb Company Thyroid receptor ligands
US7220815B2 (en) 2003-07-31 2007-05-22 E.I. Du Pont De Nemours And Company Sulfonated aliphatic-aromatic copolyesters and shaped articles produced therefrom
PL1919878T3 (pl) 2005-07-21 2011-03-31 Hoffmann La Roche Pochodne pirydazynonu jako agoniści receptora hormonu tarczycy
WO2007132475A1 (en) 2006-05-15 2007-11-22 Cadila Healthcare Limited Selective tr-beta 1 agonist
US10227563B2 (en) 2008-06-06 2019-03-12 Riken Method for culture of stem cell
TWI534144B (zh) 2009-04-20 2016-05-21 田邊三菱製藥股份有限公司 甲狀腺荷爾蒙β受體作動藥
JP5787370B2 (ja) 2009-11-05 2015-09-30 国立研究開発法人理化学研究所 幹細胞の分化誘導方法
EP2512516B1 (en) 2009-12-18 2016-02-17 The Governing Council Of The University Of Toronto Injectable polymer composition for use as a cell delivery vehicle
WO2012173207A1 (ja) 2011-06-14 2012-12-20 独立行政法人理化学研究所 網膜細胞への分化誘導方法
KR102111936B1 (ko) 2011-11-25 2020-05-18 스미또모 가가꾸 가부시끼가이샤 망막 조직 및 망막 관련 세포의 제조 방법
DK3037524T3 (da) 2013-08-23 2020-03-16 Sumitomo Chemical Co Fremgangsmåde til at fremstille nethindevæv og nethinderelaterede celler
US11492593B2 (en) 2013-10-09 2022-11-08 Healios K.K. Method for purification of retinal pigment epithelial cells
CN120384050A (zh) 2013-11-11 2025-07-29 住友化学株式会社 用于制备视网膜色素上皮细胞的方法
JP6682446B2 (ja) 2014-10-24 2020-04-15 大日本住友製薬株式会社 網膜組織の製造方法
WO2016063985A1 (ja) 2014-10-24 2016-04-28 大日本住友製薬株式会社 神経組織の製造方法
KR102675213B1 (ko) 2015-09-08 2024-06-13 스미토모 파마 가부시키가이샤 망막 색소 표피 세포의 제조 방법
CA3019357A1 (en) * 2016-04-04 2017-10-12 Biotime, Inc. Pluripotent stem cell-derived 3d retinal tissue and uses thereof
SG11201809201UA (en) 2016-04-22 2018-11-29 Sumitomo Dainippon Pharma Co Ltd Method for producing retinal tissue
US12534706B2 (en) 2017-07-20 2026-01-27 Riken Method for maturation of retinal tissue containing continuous epithelium
WO2019017491A1 (ja) 2017-07-20 2019-01-24 国立研究開発法人理化学研究所 神経組織の保存方法
CN116999555A (zh) * 2017-09-01 2023-11-07 黄玲惠 用于治疗缺血的黏性组合物
MY199810A (en) 2017-09-08 2023-11-23 Riken Cell aggregate including retinal tissue and production method therefor
CA3075877A1 (en) 2017-09-14 2019-03-21 Riken Method for producing retinal tissues
WO2019054515A1 (ja) 2017-09-14 2019-03-21 国立研究開発法人理化学研究所 背側化シグナル伝達物質又は腹側化シグナル伝達物質による錐体視細胞又は桿体視細胞の増加方法

Similar Documents

Publication Publication Date Title
JP2022079484A5 (https=)
US12410399B2 (en) Compositions and methods for treating retinal diseases
Yu et al. Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases
JP2023145686A5 (https=)
Bowen et al. Cadherin-11 coordinates cellular migration and extracellular matrix remodeling during aortic valve maturation
JP2011517659A (ja) 眼の炎症性障害を処置するための治療組成物
JP2020128434A (ja) ラミニンによる角膜の新規治療
JPWO2022054924A5 (https=)
US7943590B2 (en) Compositions and methods for treating ophthalmic disorders
WO2021068962A1 (zh) 一种用于血管新生、淋巴管新生相关疾病的多肽及其用途
CN111419876A (zh) 线粒体移植在治疗原发性扩心病中的应用
JP2020519742A5 (https=)
TW201617090A (zh) 角膜疾病或角膜損傷之預防、抑制或治療劑,細胞片、細胞培養補助劑以及細胞培養方法
CN104546692B (zh) 重组牛碱性成纤维细胞生长因子眼用凝胶
Guduric-Fuchs et al. RPE and neuronal differentiation of allotransplantated porcine ciliary epithelium-derived cells
CN115992146A (zh) 经修饰的mRNA分子及相关产品和用途
Cooksley The effect of MXene on the developmental pathways leading to posterior capsule opacification for use within an accommodative intraocular lens
CN105517564A (zh) 用于治疗人类或动物的缺血性心脏的细胞外基质的糖基化蛋白质
Shadakshari A comparative study on pterygium excision and glue free limbal conjunctival autograft with and without suture
Conlon et al. 55. Preclinical Safety Studies for AAV2-MerTK Gene Therapy Vector for Retinitis Pigmentosa
CN117100874A (zh) 纳米颗粒、其制备和应用、及包括其的眼疾药物及其制备
Kurysheva The new advantages and perspectives of Latanoprost (Xalatan, Pfizer, USA) treatment in pseudoexfoliation glaucoma
Bhardwaj et al. MicroRNAs as key modulators and therapeutic targets in glaucoma
Osei-Bempong et al. THE CORNEA, NEURAL CREST AND STEM CELLS
HK40052321A (en) Compositions and methods for treating retinal diseases